Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10085 |
| Vaccine Name | Ad26.ZEBOV |
| Disease Name | Ebola |
| Disease Classification | Hemorrhagic |
| Virus Name | Zaire ebolavirus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Approved |
| Manufacturer | Janssen Pharmaceutical |
| Year of Manufacturing | 2020 |
| Manufacturing Country | USA |
| Age | 1 year and above |
| Dosage | Single dose of Zabdeno on day 0 followed by 0.5mL dose of Mvabea post 8 week |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Adenovirus type 26 encoding the Zaire ebolavirus, Mayinga variant glycoprotein |
| Description | NA |
| Approving Organisation | US FDA, EMA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | MVA-BN-Filo |
| PMID | NA |
| Clinical Trial ID | NCT02509494 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT02509494 |
| Additional Links | https://clinicaltrials.gov/ct2/show/NCT05284097 |